Publications
Ultra-low doses of microARNs restore a strong immune response in patients with Chronic Active Epstein-Barr Virus infection (CAEBV)
N. Bahi-Jaber & G. Glady
International Journal of Scholarly Research and Reviews, 2024, 04(01), 001–008
How Nanotherapy Fails SARS-CoV-2: The BI(G)MED Experience
G. Glady & N. Bahi-Jaber
Clinical Immunology & Research, 2021; 5(2): 1-4
How to Control Convid-19 with a Nanobiotherapy ?
G. Glady
International Journal of Infectious Diseases and Research, 2020, 1-1
Cancer Stem Cells Regulation with a Sublingual Nanotherapy using Ultra Low Doses of Non-Coding RNAs
G. Glady
International Journal of Cancer Research & Therapy, 2019, 4-4-1:6
The Bio Immune(G)ene medicine or how to use a maximum of molecular resources of the cell for therapeutic purposes
G. Glady
Edelweiss Applied Science and Technology, 2019, 3 : 26-29
The Interplay between MiRNAs and LncRNAs in the Pathogenesis of Asthmatic Diseases
G. Glady
Archives of Immunology and Allergy, 2019, 2-2 : 1-9
Spondylitis Associated with Parvovirus B19 and Treated with a Novel Nanobiological Therapy Based on MicroRNAs: A Case Report
O. Cuvelier & G. Glady
Clinical Immunology and Infectious Diseases, 2018, 2-1
Bio Immune(G)ene Medicine and the Use of miRNAs to Regulate the Cell
M.C.P Santilari & G. Glady
Advances in Bioengineering & Biomedical Science Research, 2018, 1-2 : 6
Epstein – Barr virus Reactivation Associated with an Increased Thymidine Kinase and Normalized by an Immuno Modulatory Nano-Therapy: Three Case Reports
G. Glady
Journal of Clinical & Experimental Immunology, 2018, 3-1 : 5
Clinical efficacy of implementing Bio Immune (G) ene MEDicine in the treatment of chronic asthma with the objective of reducing or removing effectively corticosteroid therapy: A novel approach and promising results
G. Glady
Experimental and Therapeutic Medicine, 2018, 15: 5133-5140, 2018
Bio immune(G)en medicine in allergic diseases especially asthma
G. Glady
World Allergy Organization Journal, 2015, 8 (Suppl 1):A58
Therapeutic Use of MicroRNAs to Prevent and Control Allergic Rhinosinusitis
G. Glady
Clinical Immunology & Research, 2018, 2-1 : 1